Medtronic, Inc. (MDT) PT Lowered to $125 at Stifel

Medtronic, Inc. (MDT) PT Lowered to $111 at Truist Securities

Truist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $111.00 (from $121.00) while maintaining a Hold rating following earnings.

The analyst commented, "We stay at HOLD following MDT's disappointing F4Q & below CNS F1Q/FY23 guide. We appreciate MDT's... More

Medtronic, Inc. (MDT) PT Lowered to $117 at Cowen; FY23 Can Be a Year of Real Pipeline Progress

Cowen analyst Joshua Jennings lowered the price target on Medtronic, Inc. (NYSE: MDT) to $117.00 (from $125.00) while maintaining an Outperform rating following earnings. Despite weak guidance, the analyst said FY23 can be a year of real pipeline progress.

The analyst commented, "MDT delivered... More

UPDATE: Needham & Company Downgrades Medtronic, Inc. (MDT) to Hold

(Updated - May 27, 2022 6:37 AM EDT)

Needham & Company analyst Michael Matson downgraded Medtronic, Inc. (NYSE: MDT) from Buy to Hold.

The analyst commented, "MDT's F4Q22 revenue and EPS missed consensus and organic revenue growth slowed to 1.4% from 1.6% in F3Q22.... More

Medtronic, Inc. (MDT) PT Lowered to $117 at CFRA

CFRA lowered its price target on Medtronic, Inc. (NYSE: MDT) to $117.00 (from $119.00) while maintaining a Buy rating.... More

Medtronic (MDT) Sinks 6% on Disappointing Earnings and Guidance as Macro Issues Weigh, Analyst Warns Issues Might Not Resolve 'Near Term'

Shares of Medtronic plc (NYSE: MDT) fell 6% in early trading Thursday after missing on the top and bottom-line in its fourth quarter and providing weaker guidance as macro factors hit the medtech giant.

Fourth quarter non-GAAP diluted EPS rose 2% to $1.52 but fell shy of Wall Street estimates of $1.57.

Revenue fell 1% to $8.089 billion versus the consensus estimate of $8.44 billion. U.S. revenue fell 2% in the quarter to $4.097 billion.

"Global supply chain and COVID-19 controls in China... More

Medtronic (MDT) Misses Q4 EPS by 5c, Offers Guidance

Medtronic (NYSE: MDT) reported Q4 EPS of $1.52, $0.05 worse than the analyst estimate of $1.57. Revenue for the quarter came in at $8.09 billion versus the consensus estimate of $8.44 billion.

GUIDANCE:

Medtronic sees FY2023 EPS of $5.53-$5.65, versus the consensus of... More

Medtronic (MDT) Raises Quarterly Dividend 7.9% to $0.68; 2.6% Yield

Medtronic (NYSE: MDT) declared a quarterly dividend of $0.68 per share, or $2.72 annualized. This is a 7.9% increase from the prior dividend of $0.63.

The dividend will be payable on July 15, 2022, to stockholders of record on June 24, 2022, with an ex-dividend date of June 23,... More